数据表1:中国透明细胞肾细胞癌患者综合基因组图谱

中国880例透明细胞肾细胞癌患者的NGS基因组图谱数据,含临床信息、PD-L1表达、TMB及MSI等,用于分子特征与个体化治疗研究。

NIAID Data Ecosystem
浏览 16
多模态clear cell renal cell carcinomanext-generation sequencingVHLPBRM1DDR genes
DataSheet_1_Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients

基本信息

模态
多模态
大小
0.000423976 GB
许可
CC BY 4.0
创建/更新时间
2026-10-17
版本
v1

资源简介

数据表1:中国透明细胞肾细胞癌患者综合基因组图谱

【一句话概览】

本数据集是 figshare 公开的多模态数据集,收录 1 个文件、合计 423.98 KB,主题涵盖 clear cell renal cell carcinoma、next-generation sequencing、VHL、PBRM1、DDR genes,可用于跨模态对齐与融合建模研究,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《DataSheet_1_Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.docx》。配套论文《Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma》发表于 Translational Andrology and Urology(2020),DOI:10.21037/tau-20-1410。源站首次发布:2021-09-09。

【数据内容】

源站原始描述:Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma (RCC). The genomic landscape in Chinese ccRCC needs to be elucidated. Herein, we investigated the molecular features of Chinese ccRCC patients. Genomic profiling of DNA was performed through next-generation sequencing (NGS) in Chinese patients with ccRCC between January 2017 and March 2020. Clinical information including age, gender, and tumor histology was collected. Immunohistochemistry (IHC) staining fo…

【数据结构与技术规格】

文件数 1 个,合计 423.98 KB。DataSheet_1_Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,423.98 KB。数据集 DOI:10.3389/fonc.2021.697219.s001。

【主题与分类】

源站学科分类:Cancer、Haematological Tumours、Molecular Targets、Radiation Therapy、Oncology and Carcinogenesis not elsewhere classified、Solid Tumours。主题标签:clear cell renal cell carcinoma、next-generation sequencing、VHL、PBRM1、DDR genes。

【适用方向】

多模态数据适合跨模态对齐、融合建模与联合表征学习方向的研究。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Comprehensive_Genomic_Landscape_in_Chinese_Clear_Cell_Renal_Cell_Carcinoma_Patients_docx/16594964

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Huang, Jiwei; Cai, Wen; Cai, Biao; Kong, Wen; Zhai, Wei; Zhang, Jin; et al. (2021). DataSheet_1_Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.docx. Frontiers. Dataset

【使用注意】

· 源站最后修改于 2023-06-06,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "DataSheet_1_Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.docx" "https://ndownloader.figshare.com/files/30717974"

文件清单

  • DataSheet_1_Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.docx(423.98 KB)

文件总体积 423.98 KB(源站 API 实测)。

数据说明

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma (RCC). The genomic landscape in Chinese ccRCC needs to be elucidated. Herein, we investigated the molecular features of Chinese ccRCC patients. Genomic profiling of DNA was performed through next-generation sequencing (NGS) in Chinese patients with ccRCC between January 2017 and March 2020. Clinical information including age, gender, and tumor histology was collected. Immunohistochemistry (IHC) staining for PD-L1 expression was performed using PD-L1 IHC 22C3 pharmDx assay or Ventana PD-L1 SP263 assay. Data analyses were performed using R 3.6.1. A total of 880 Chinese ccRCC patients who have undergone NGS were included in this study. The most common somatic alterations were detected in VHL (59.7%), PBRM1 (18.0%), SETD2 (12.2%), BAP1 (10.2%), and TP53 (9.4%). Compared with The Cancer Genome Atlas (TCGA) database, a higher mutation frequency of VHL (59.7% vs. 50.0%, p < 0.001) and TP53 (9.4% vs. 3.5%, p < 0.001) and a lower mutation frequency of PBRM1 (18.0% vs. 31.0%, p < 0.001) were found in the Chinese cohort. Of the 460 patients who were evaluated for PD-L1 expression, 139 (30.2%) had positive PD-L1 expression. The median tumor mutational burden (TMB) value was 4.5 muts/Mb (range, 0–46.0). Five (0.7%) patients were identified as microsatellite instability-high (MSI-H). Furthermore, 52 (5.9%) patients were identified to carry pathogenic or likely pathogenic germline mutations in 22 cancer predisposition genes. This is the first large-scale comprehensive genomic analysis for Chinese ccRCC patients, and these results might provide a better understanding of molecular features in Chinese ccRCC patients, which can lead to an improvement in the personalized treatment for these patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fonc.2021.697219.s001(source: https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Comprehensive_Genomic_Landscape_in_Chinese_Clear_Cell_Renal_Cell_Carcinoma_Patients_docx/16594964)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案